Covered recipient · General Payments record
MELISSA JENKINS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$9,300.73
- Reported across 337 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,201.18 | 55 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TAIHO ONCOLOGY, INC. | $206.38 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $137.91 | 9 |
| Tempus AI, Inc | $98.18 | 2 |
| Acerta Pharma LLC | $97.13 | 4 |
| GlaxoSmithKline, LLC. | $52.88 | 2 |
| SOBI, INC | $46.00 | 1 |
| ARRAY BIOPHARMA INC | $37.82 | 1 |
| Ipsen Biopharmaceuticals, Inc | $37.04 | 2 |
| PFIZER INC. | $35.45 | 2 |
| Karyopharm Therapeutics Inc. | $32.79 | 1 |
| ACCORD HEALTHCARE, INC. | $32.13 | 1 |
| ABBVIE INC. | $30.75 | 2 |
| SpringWorks Therapeutics, Inc. | $29.31 | 1 |
| GENZYME CORPORATION | $28.79 | 1 |
| JAZZ PHARMACEUTICALS INC. | $27.09 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.21 | 1 |
| Astellas Pharma US Inc | $25.49 | 1 |
| Coherus Biosciences Inc. | $21.87 | 1 |
| Acrotech Biopharma Inc. | $20.96 | 1 |
| Daiichi Sankyo Inc. | $20.65 | 1 |
| Gilead Sciences, Inc. | $20.41 | 1 |
| BeiGene USA, Inc. | $19.98 | 1 |
| EISAI INC. | $19.47 | 1 |
| Janssen Biotech, Inc. | $18.57 | 1 |
| Merck Sharp & Dohme Corporation | $16.55 | 1 |
| SERVIER PHARMACEUTICALS LLC | $15.83 | 1 |
| TerSera Therapeutics LLC | $15.78 | 1 |
| Deciphera Pharmaceuticals Inc. | $14.97 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.